Morning migraine?

approximately

20%

of adult episodic migraine patients awake with migraine1

Professional organizations recommend a non-oral triptan for patients with migraine on waking.2,3

MY GAIN:

With ZEMBRACE SymTouch, my patients get fast relief, so they can take on the rest of their day4

Patients experienced migraine pain relief in as little as 10 minutes (17% for sumatriptan 3 mg vs 5% for placebo).4 And in one study, subcutaneous sumatriptan was shown to be effective when administered early or late during a migraine attack.5

Rapid-onset migraine?

approximately

44%

of adult migraine patients experience rapid-onset migraine1

Professional organizations recommend a non-oral triptan for patients who experience rapid escalation of pain intensity.2,3

MY GAIN:

With ZEMBRACE SymTouch, powerful relief sets in fast4

Inadequate management of acute attacks can lead to an increased risk of chronic migraine.6

 Migraine with nausea?

approximately

73%

of migraine patients suffer from nausea, vomiting, or gastroparesis, which may impair the absorption and efficacy of orally administered treatments7,8

Treatment guidelines recommend a non-oral triptan for patients who experience severe nausea or vomiting.9

MY GAIN:

For my patients, ZEMBRACE SymTouch is an easy-to-use pen that bypasses the stomach10-12*

ZEMBRACE SymTouch is a non-oral treatment option that features a simple two-step injection process.10,11†

*Pen=autoinjector.
Please see complete Instructions for Use. As with all injection medications, be sure that the injection site is properly cleaned and that the used needle is properly disposed of immediately after use.